Company / Working Capital
Bio-Rad Laboratories Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$2.4B
FY2025
5-year range
$1.3B / $2.6B
FY2021-FY2025
Trend
-6.8%
vs FY2024
Sector context
#19 of 160
Health Care
What the data says
Bio-Rad Laboratories's working capital of $2.4B is higher than 88% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $1.3B in FY2019 to $2.6B in FY2022.
Based on SEC 10-K filings.
$2.4B in FY2025 with a 5-year CAGR of +9.6%. Top quartile in the Health Care sector.
Declined from $2.5B to $2.4B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
+215.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2025, working capital decreased 6.8% year-over-year.
- Ranks #19 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4B | -6.8% |
| FY2024 | $2.6B | +1.5% |
| FY2023 | $2.5B | -2.5% |
| FY2022 | $2.6B | +97.7% |
| FY2021 | $1.3B | -13.2% |
| FY2020 | $1.5B | +18.3% |
| FY2019 | $1.3B | -18.9% |
| FY2018 | $1.6B | +6.7% |
| FY2017 | $1.5B | +7.3% |
| FY2016 | $1.4B | +2.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026